329 related articles for article (PubMed ID: 30120966)
21. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
22. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract][Full Text] [Related]
24. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
25. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
26. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.
Agarwal S; Kakkar A; Damle NA; Kumar C; Sarangi J; Subudhi K; Jain D; Sharma MC
Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181
[TBL] [Abstract][Full Text] [Related]
27. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
Allison DB; Bishop JA; Ali SZ
Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
[TBL] [Abstract][Full Text] [Related]
28. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
[TBL] [Abstract][Full Text] [Related]
29. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
[TBL] [Abstract][Full Text] [Related]
32. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
[TBL] [Abstract][Full Text] [Related]
33. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
34. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
35. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
[TBL] [Abstract][Full Text] [Related]
36. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
37. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.
Agaimy A; Rau TT; Hartmann A; Stoehr R
Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755
[TBL] [Abstract][Full Text] [Related]
38. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
40. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]